Bacterial Antigen Ingredients TRIZ Cases

Prolonged incubation before size separation stabilizes 19F polysaccharide-protein conjugates and reduces free polysaccharide.

Lachnospiraceae flagellin-related peptides pair with immune checkpoint therapy to stimulate CD8+ T cells in non-responding melanoma patients.

Controlled activation and reductive amination improve serotype 3 conjugation consistency while supporting immunogenicity and higher molecular weight.

Low-affinity FimH lectin mutations help induce inhibitory antibodies that block E. coli adhesion in UTI vaccine compositions.

Latent viral infections evade NK-cell therapy when viral proteins are hidden; HDAC inhibitors induce their expression for targeted immune treatment.

See how protective materials shield IgY antibodies from gastric acid and digestive enzymes during oral avian treatment.

Elevated phosphate, sulfate, or related oxyanions help chemical inactivation preserve antigenic epitopes and immunogenicity for vaccine production.

A probiotic strain suppresses mixed periodontal biofilms, lowers inflammatory cytokines, and limits oral colonization without antibiotics.

PS-binding biomolecules paired with disease-specific antigens restore effector function in exhausted memory T cells and support infection diagnostics.

See how an alphavirus RNA replicon vaccine given to pregnant sows transfers antibodies through colostrum to protect piglets from diverse IAV-S strains.

Rare L-aminogalacturonic acid, 1,2-cis bonds, and acetamidino groups complicate synthesis; chemical assembly improves purity and yield.

Multiple OspA fusion-protein doses build sustained antibodies against several Borrelia serotypes while managing schedule complexity.

Concurrent bacterial antigen and mRNA vaccination combines antibody and cell-mediated immunity for stronger protection against COVID-19 and bacterial infections.

Nanoparticles carrying an iNKT agonist and bacterial-antigen mRNA stimulate cellular and innate immunity against intracellular bacteria.

Sequentially administered glycoconjugate compositions broaden pneumococcal serotype coverage while limiting antigenic interference.

Specific fHbp substitutions such as S32V and L123R improve stability while preserving antibody recognition for cross-variant protection.

See how isolated spore-forming bacterial strains create standardized compositions that inhibit pathogens and help restore a healthy gut microbiome.

Applying vaccine gel to sow teats lets nursing piglets self-administer Lawsonia or Salmonella vaccines, reducing handling and stress.

Integrated acid-resistance genes help oral Ty21a survive stomach acid while expressing Shigella antigens for bivalent protection.

A mutant PB2 segment creates a biologically contained influenza vaccine that supports robust immunity while limiting reversion and pathogenicity.

PAL- and LAAD-expressing bacteria use gut phenylalanine uptake to lower blood levels, reducing reliance on strict PKU diets.

Eight-membered cycloalkyne groups enable copper-free click coupling of saccharides into uniform conjugates with enhanced immunogenicity.

Bacillus subtilis vaccine vehicles are microencapsulated in a visco-elastic carrier for gastric protection and duodenal release.

A live attenuated BPZE1f3 strain stably produces Fim2 and Fim3 to improve protection against Fim3-only pertussis isolates.

Enriched lysates transfer lipid-linked oligosaccharides to FDA-approved carrier proteins for faster, lyophilizable bioconjugate vaccine production.